Stocks and Investing Stocks and Investing
Fri, August 27, 2021
Thu, August 26, 2021
Wed, August 25, 2021
Tue, August 24, 2021
Mon, August 23, 2021
Fri, August 20, 2021

Arlinda Lee Maintained (BNTX) at Strong Buy with Increased Target to $450 on, Aug 20th, 2021


Published on 2024-10-27 17:43:52 - WOPRAI
  Print publication without navigation


Arlinda Lee of Canaccord Genuity, Maintained "BioNTech SE" (BNTX) at Strong Buy with Increased Target from $240 to $450 on, Aug 20th, 2021.

Arlinda has made no other calls on BNTX in the last 4 months.



There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 3 agree with Arlinda's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Daina Graybosch of "SVB Leerink" Maintained at Hold with Increased Target to $293 on, Friday, August 13th, 2021
  • Robert Burns of "HC Wainwright & Co." Maintained at Hold with Increased Target to $330 on, Wednesday, August 11th, 2021
  • Chris Shibutani of "Goldman Sachs" Initiated at Hold and Held Target at $173 on, Tuesday, May 18th, 2021


These are the ratings of the 2 analyists that currently disagree with Arlinda


  • Olga Smolentseva of "Bryan Garnier" Upgraded from Hold to Strong Buy and Held Target at $451 on, Wednesday, August 11th, 2021
  • Simon Baker of "Redburn Partners" Downgraded from Hold to Strong Sell on, Wednesday, June 16th, 2021